In CHF rats with BD+VD, microinjection of losartan, an antagonist of AT1 receptors, into the PVN abolished the CSAR and decreased the RSNA and MAP, while Ang II potentiated the CSAR and increased RSNA and MAP which is abolished by losartan [16]. The gene discussed is AGTR1; the disease is congestive heart failure.